Skip to content

Clinical trials

Observational Musculoskeletal Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Phase: Observational Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20193
20203
20222
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Unknown status3
Active, not recruiting2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company2
Calcilytix Therapeutics, Inc., a BridgeBio company1
Cambridge University Hospitals NHS Foundation Trust1
DJO UK Ltd1
East Lancashire Hospitals NHS Trust1
Endo USA Inc., a Keenova Therapeutics Company1
Imperial College Healthcare NHS Trust1
Keele University1
Oxford Brookes University1
Queen Mary University of London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases15
Muscular Diseases3
Wounds and Injuries3
Bone Diseases2
Dwarfism2
Genetic Diseases, Inborn2
Mucopolysaccharidosis IV2
Osteochondrodysplasias2
Achondroplasia1
Arthritis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.